Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

SIG FINANCIAL STATEMENTS

Sigma Healthcare Ltd — balance sheet, income statement and cash flow trends

SIGSigma Healthcare Ltd

🇦🇺 Australia · AU · Healthcare · Medical Distribution

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
02 B4 B202020212022202320242025

Profit Funnel

Q1 2025 · TTM
Revenue4.8 B A$Gross Profit268.6 M A$ · 6%Operating Income-44.2 M A$ · -1%Pre-tax Income11.1 M A$ · 0%Net Income-13.8 M A$ · -0%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue4.8 B A$+32.3%
Gross Profit268.6 M A$+19.9%
Operating Income-44.2 M A$—
EBITDA41.6 M A$-17.1%
Net Income-13.8 M A$-864.3%

Peer Comparison· Medical Distribution

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
SIG45.7%5.5%0.9%-0.3%
HSIC5.6%29.7%7.5%3.0%
CAH12.8%3.7%1.2%0.6%
COR5.9%3.5%1.5%0.8%
MCK12.4%3.6%1.7%1.2%
SELEC11.4%9.3%3.1%0.6%
Industry median11.4%5.5%1.7%0.8%
CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
SIG45.7%5.5%0.9%-0.3%
EBO1.7%14.0%4.3%1.8%
Industry median11.4%5.5%1.7%0.8%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B202020212022202320242025

Capital Structure

Q1 2025
Total Assets1.8 B
  • Equity837.9 M A$45%
  • Current Liabilities865 M A$46%
  • Long-term Liabilities160.2 M A$9%

Key Figures

YoY change
Total Assets1.8 B A$+52.3%
Total Liabilities991.3 M A$+36.9%
Total Equity837.9 M A$+76.1%
Cash & ST Investments14.6 M A$-12.5%
Total Debt132.1 M A$-41.8%
Net Debt117.5 M A$-44.1%

Peer Comparison· Medical Distribution

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
SIG1.5915.8%2.8245.8%
HSIC1.36114.8%3.6028.9%
CAH0.91-314.8%1.65-5.0%
COR0.95364.5%2.034.2%
MCK0.85-396.6%0.66-2.6%
SELEC1.3717.7%-1.2835.3%
Industry median1.2417.7%2.0328.9%
CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
SIG1.5915.8%2.8245.8%
EBO1.2481.9%3.8536.3%
Industry median1.2417.7%2.0328.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0202020212022202320242025

Cash Flow Bridge

Q1 2025 · TTM
-300 M-200 M-100 M0-315.6 M A$Operating-1.6 M A$Investing-24.7 M A$Financing-341.9 M A$Net Change

Key Figures

YoY change
Operating Cash Flow-315.6 M A$-321.1%
Capital Expenditures7.9 M A$-73.1%
Free Cash Flow-323.5 M A$-385.4%
Dividends Paid-15.8 M A$-205.5%

Peer Comparison· Medical Distribution

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
SIG-6.5%-6.7%0.2%2,280.0%
HSIC4.3%3.2%1.1%146.3%
CAH2.0%1.8%0.2%321.3%
COR0.7%0.5%0.2%89.3%
MCK1.5%1.5%0.1%129.3%
SELEC0.4%1.0%0.3%68.3%
Industry median1.5%1.5%0.2%146.3%
CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
SIG-6.5%-6.7%0.2%2,280.0%
EBO2.8%1.6%0.4%160.0%
Industry median1.5%1.5%0.2%146.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SIG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.